355 related articles for article (PubMed ID: 12105116)
21. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
Johnson MP; Huang XM; Nichols DE
Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189
[TBL] [Abstract][Full Text] [Related]
22. Peripheral nerve stimulation increases serotonin and dopamine metabolites in rat spinal cord.
Men DS; Matsui Y
Brain Res Bull; 1994; 33(6):625-32. PubMed ID: 7514945
[TBL] [Abstract][Full Text] [Related]
23. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
[TBL] [Abstract][Full Text] [Related]
24. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents.
Ali SF; Newport GD; Slikker W
Ann N Y Acad Sci; 1996 Oct; 801():187-98. PubMed ID: 8959033
[TBL] [Abstract][Full Text] [Related]
25. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
Marona-Lewicka D; Rhee GS; Sprague JE; Nichols DE
Pharmacol Biochem Behav; 1996 Jan; 53(1):99-105. PubMed ID: 8848466
[TBL] [Abstract][Full Text] [Related]
26. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
27. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
28. Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum.
Gagnaire F; Micillino JC
Toxicology; 2006 Jan; 217(2-3):91-104. PubMed ID: 16246478
[TBL] [Abstract][Full Text] [Related]
29. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
[TBL] [Abstract][Full Text] [Related]
30. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats.
Ferré S; Cortés R; Artigas F
J Neurosci; 1994 Aug; 14(8):4839-46. PubMed ID: 7519257
[TBL] [Abstract][Full Text] [Related]
31. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.
Nash JF; Nichols DE
Eur J Pharmacol; 1991 Jul; 200(1):53-8. PubMed ID: 1722755
[TBL] [Abstract][Full Text] [Related]
32. Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine.
Pereira FC; Imam SZ; Gough B; Newport GD; Ribeiro CF; Slikker W; Macedo TR; Ali SF
J Neural Transm (Vienna); 2002 Sep; 109(9):1151-8. PubMed ID: 12203042
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
Fattaccini CM; Gozlan H; Hamon M
Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
[TBL] [Abstract][Full Text] [Related]
34. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
[TBL] [Abstract][Full Text] [Related]
35. Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
Matos FF; Guss V; Korpinen C
Neuropeptides; 1996 Aug; 30(4):391-8. PubMed ID: 8914867
[TBL] [Abstract][Full Text] [Related]
36. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
37. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
38. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
39. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
[TBL] [Abstract][Full Text] [Related]
40. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
